CAI
Caris Life Sciences, Inc.
Company overview
- Market capitalization
- $8.97B
- Employees
- 1,846
- Latest publication
- 2026-09-29
About Caris Life Sciences, Inc.
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 263,712,000USD | 216,174,000USD | 292,886,000USD | 216,833,000USD | 181,398,000USD | 120,915,000USD | 100,049,000USD | 80,677,000USD |
| Cost Of Revenue | 84,116,000USD | 74,826,000USD | 71,972,000USD | 69,327,000USD | 67,713,000USD | 63,852,000USD | 62,495,000USD | 54,563,000USD |
| Gross Profit | 179,596,000USD | 141,348,000USD | 220,914,000USD | 147,506,000USD | 113,685,000USD | 57,063,000USD | 37,554,000USD | 26,114,000USD |
| Research Development | 32,358,000USD | 5,374,000USD | 31,845,000USD | 21,624,000USD | 25,047,000USD | 23,066,000USD | 24,787,000USD | 34,376,000USD |
| Selling General Administrative | 66,548,000USD | 59,708,000USD | 56,507,000USD | 51,973,000USD | 64,367,000USD | 53,362,000USD | 41,068,000USD | 45,472,000USD |
| Selling And Marketing Expenses | 53,764,000USD | 45,043,000USD | 44,151,000USD | 41,267,000USD | — | 38,586,000USD | — | 38,491,000USD |
| General And Administrative Expenses | 66,548,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 152,670,000USD | 136,066,000USD | 132,503,000USD | 114,864,000USD | 95,696,000USD | 115,015,000USD | -29,457,000USD | 118,339,000USD |
| Operating Income | 26,926,000USD | 5,282,000USD | 88,411,000USD | 32,642,000USD | 17,989,000USD | -57,952,000USD | 67,011,000USD | -92,225,000USD |
| Total Other Income Expense Net | -27,540,000USD | -5,926,000USD | -6,454,000USD | -8,317,000USD | -89,779,000USD | -44,629,000USD | -133,197,000USD | -18,803,000USD |
| Interest Expense | 9,228,000USD | 12,809,000USD | 11,356,000USD | 13,507,000USD | 19,208,000USD | 12,782,000USD | 13,674,000USD | 9,290,000USD |
| Income Before Tax | -614,000USD | -644,000USD | 81,957,000USD | 24,325,000USD | -71,790,000USD | -102,581,000USD | -66,186,000USD | -111,028,000USD |
| Income Tax Expense | 23,000USD | -134,000USD | — | — | — | — | — | — |
| Net Income | -637,000USD | -510,000USD | 81,957,000USD | 24,325,000USD | -71,790,000USD | -102,581,000USD | -66,186,000USD | -111,028,000USD |
| Net Income Applicable To Common Shares | -637,000USD | — | — | — | — | — | — | — |
| Unclassified Operating Expenses | — | 25,941,000USD | — | — | 6,282,000USD | — | -95,312,000USD | — |
| Interest Income | — | 6,834,000USD | 7,015,000USD | 7,360,000USD | 1,618,000USD | 503,000USD | 2,640,000USD | 1,768,000USD |
| Net Interest Income | — | -5,975,000USD | -4,341,000USD | -6,147,000USD | -17,590,000USD | -12,279,000USD | -11,034,000USD | -7,522,000USD |
| Tax Provision | — | -134,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | -510,000USD | 81,957,000USD | 24,325,000USD | -71,790,000USD | -102,581,000USD | -66,186,000USD | -111,028,000USD |
| Ebit | — | 5,282,000USD | 93,313,000USD | 37,832,000USD | -52,582,000USD | -89,799,000USD | -52,512,000USD | -101,738,000USD |
| Ebitda | — | 10,347,000USD | 97,604,000USD | 42,702,000USD | -46,173,000USD | -82,754,000USD | -40,902,000USD | -84,033,000USD |
| Depreciation And Amortization | — | 5,065,000USD | 4,291,000USD | 4,870,000USD | 6,409,000USD | 7,045,000USD | 11,610,000USD | 17,705,000USD |
| Reconciled Depreciation | — | 5,065,000USD | 4,291,000USD | 4,870,000USD | 6,409,000USD | 7,045,000USD | 11,610,000USD | 17,705,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 812,033,000USD | 412,260,000USD | 306,128,000USD | 258,485,000USD | 294,013,000USD | 416,540,000USD | 432,098,000USD | 348,393,000USD |
| Cost Of Revenue | 272,865,000USD | 233,478,000USD | 216,818,000USD | 178,463,000USD | 109,856,000USD | 216,026,000USD | 218,468,000USD | 179,107,000USD |
| Gross Profit | 539,168,000USD | 178,782,000USD | 89,310,000USD | 80,022,000USD | 184,157,000USD | 200,514,000USD | 213,630,000USD | 169,286,000USD |
| Research Development | 45,314,000USD | 113,916,000USD | 116,883,000USD | 101,268,000USD | — | — | — | — |
| Selling General Administrative | 224,965,000USD | 173,559,000USD | 151,953,000USD | 156,154,000USD | 27,312,000USD | 52,699,000USD | 50,305,000USD | 42,699,000USD |
| Selling And Marketing Expenses | 167,506,000USD | 148,301,000USD | 139,525,000USD | 138,356,000USD | — | — | — | — |
| Unclassified Operating Expenses | 56,270,000USD | — | — | — | 17,758,000USD | 17,533,000USD | 14,545,000USD | 20,918,000USD |
| Total Operating Expenses | 494,055,000USD | 435,904,000USD | 408,861,000USD | 395,778,000USD | 45,070,000USD | 70,232,000USD | 64,850,000USD | 63,617,000USD |
| Operating Income | 45,113,000USD | -257,122,000USD | -319,551,000USD | -315,756,000USD | 139,087,000USD | 130,282,000USD | 148,780,000USD | 105,669,000USD |
| Interest Income | 16,497,000USD | 7,122,000USD | 11,258,000USD | 947,000USD | — | — | — | — |
| Interest Expense | 56,853,000USD | 50,025,000USD | 31,610,000USD | 26,680,000USD | 61,565,000USD | 79,158,000USD | 78,345,000USD | 53,052,000USD |
| Net Interest Income | -40,356,000USD | -42,903,000USD | -20,352,000USD | -25,733,000USD | — | — | — | — |
| Income Before Tax | -68,088,000USD | -281,890,000USD | -341,415,000USD | -320,827,000USD | 29,533,000USD | 55,213,000USD | 81,483,000USD | 57,199,000USD |
| Income Tax Expense | 469,869,000USD | — | — | — | 1,800,000USD | 4,192,000USD | 2,887,000USD | -14,861,000USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | — | — | — | — |
| Net Income | -537,957,000USD | -281,890,000USD | -341,415,000USD | -320,827,000USD | 27,733,000USD | 31,011,000USD | 78,596,000USD | 72,060,000USD |
| Net Income From Continuing Ops | -68,088,000USD | -281,890,000USD | -341,415,000USD | -320,827,000USD | — | — | — | — |
| Ebit | -11,235,000USD | -231,865,000USD | -309,805,000USD | -294,147,000USD | 143,807,000USD | 134,371,000USD | 159,828,000USD | 110,251,000USD |
| Ebitda | 11,380,000USD | -182,952,000USD | -260,804,000USD | -245,894,000USD | 254,457,000USD | 248,298,000USD | 283,311,000USD | 223,514,000USD |
| Depreciation And Amortization | 22,615,000USD | 48,913,000USD | 49,001,000USD | 48,253,000USD | 110,650,000USD | 113,927,000USD | 123,483,000USD | 113,263,000USD |
| Reconciled Depreciation | 22,615,000USD | 48,913,000USD | 49,001,000USD | 48,253,000USD | — | — | — | — |
| Total Other Income Expense Net | -113,201,000USD | -24,768,000USD | -21,864,000USD | -5,071,000USD | -109,554,000USD | -75,069,000USD | -67,297,000USD | -48,470,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,229,620,000USD | 1,162,388,000USD | 1,125,663,000USD | 984,571,000USD | 955,058,000USD | 291,583,000USD | — | — |
| Short Term Investments | 102,200,000USD | 2,315,000USD | 2,295,000USD | 2,272,000USD | 2,249,000USD | 2,225,000USD | — | — |
| Total Current Assets | 1,057,828,000USD | 1,014,180,000USD | 997,800,000USD | 854,245,000USD | 833,319,000USD | 171,233,000USD | — | — |
| Other Current Assets | 5,106,000USD | 100,201,000USD | 85,566,000USD | 22,752,000USD | 20,634,000USD | 21,081,000USD | — | — |
| Other Non Current Assets | 56,732,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 637,886,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 191,437,000USD | 143,896,000USD | 127,145,000USD | 86,030,000USD | 90,180,000USD | 162,554,000USD | — | — |
| Other Current Liabilities | 105,273,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 53,476,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 591,734,000USD | 593,490,000USD | 577,307,000USD | 478,364,000USD | 452,904,000USD | -2,599,865,000USD | — | — |
| Total Equity Including Noncontrolling Interest | 591,734,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 178,000USD | 173,000USD | — | 164,000USD | 95,000USD | 60,093,000USD | — | — |
| Long Term Debt | 392,973,000USD | 381,402,000USD | 378,450,000USD | 376,296,000USD | 373,611,000USD | 316,643,000USD | — | — |
| Deferred Revenue | 20,517,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 539,000USD | — | — | — | — | — | — | — |
| Net Receivables | 116,888,000USD | 90,517,000USD | 112,140,000USD | 26,697,000USD | 50,889,000USD | 80,174,000USD | 88,244,000USD | — |
| Property Plant Equipment Net | 95,716,000USD | 82,669,000USD | 63,170,000USD | 63,997,000USD | 61,315,000USD | 61,651,000USD | 67,817,000USD | — |
| Goodwill | 19,344,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 85,986,000USD | 69,802,000USD | 39,206,000USD | 28,999,000USD | 28,728,000USD | 24,226,000USD | — | — |
| Short Term Debt | 6,367,000USD | 173,000USD | 169,000USD | 6,614,000USD | 7,386,000USD | 66,116,000USD | — | — |
| Common Stock | 283,000USD | 284,000USD | 283,000USD | 283,000USD | 282,000USD | 38,000USD | — | — |
| Retained Earnings | -2,549,883,000USD | -2,549,246,000USD | -2,548,736,000USD | -2,630,693,000USD | -2,655,018,000USD | -2,583,231,000USD | — | — |
| Accumulated Other Comprehensive Income | 529,000USD | 893,000USD | 936,000USD | 748,000USD | 669,000USD | 245,000USD | — | — |
| Cash And Equivalents | 690,915,000USD | — | — | — | — | — | — | — |
| Total Liab | — | 568,898,000USD | 548,356,000USD | 506,207,000USD | 502,154,000USD | 2,891,448,000USD | — | — |
| Other Current Liab | — | 73,921,000USD | 87,770,000USD | 50,417,000USD | 48,726,000USD | 64,548,000USD | — | — |
| Capital Stock | — | 284,000USD | 283,000USD | 283,000USD | 282,000USD | 38,000USD | — | — |
| Good Will | — | 19,344,000USD | 19,344,000USD | 19,344,000USD | 19,344,000USD | 19,344,000USD | — | — |
| Cash | — | 821,147,000USD | 797,799,000USD | 753,221,000USD | 718,934,000USD | 31,201,000USD | — | — |
| Cash And Short Term Investments | — | 823,462,000USD | 800,094,000USD | 755,493,000USD | 721,183,000USD | 33,426,000USD | — | — |
| Net Debt | — | -820,974,000USD | -418,807,000USD | -326,483,000USD | -299,954,000USD | 388,625,000USD | — | — |
| Short Long Term Debt Total | — | 173,000USD | 378,992,000USD | 426,738,000USD | 418,980,000USD | 419,826,000USD | — | — |
| Inventory | — | 76,289,000USD | 63,625,000USD | 49,303,000USD | 40,613,000USD | 36,552,000USD | — | — |
| Property Plant Equipment Gross | — | 328,405,000USD | 304,150,000USD | 304,449,000USD | 303,352,000USD | 297,289,000USD | 296,426,000USD | — |
| Common Stock Shares Outstanding | — | 282,562,013shares | 1,672,056,160shares | 297,211,838shares | 276,000,358shares | 254,788,878shares | — | 254,788,878shares |
| Non Current Assets Total | — | 148,208,000USD | 127,863,000USD | 130,326,000USD | 121,739,000USD | 120,350,000USD | — | — |
| Non Current Liabilities Total | — | 425,002,000USD | 421,211,000USD | 420,177,000USD | 411,974,000USD | 2,728,894,000USD | — | — |
| Non Currrent Assets Other | — | 46,195,000USD | 45,349,000USD | 46,985,000USD | 41,080,000USD | 39,355,000USD | 40,844,000USD | — |
| Net Working Capital | — | 870,284,000USD | 870,655,000USD | 768,215,000USD | 743,139,000USD | 8,679,000USD | — | — |
| Unclassified Current Assets | — | -76,289,000USD | -63,625,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 43,600,000USD | 42,761,000USD | 43,881,000USD | 38,363,000USD | 2,412,251,000USD | — | — |
| Unclassified Equity | — | 3,141,275,000USD | 3,124,541,000USD | 3,107,743,000USD | 3,106,689,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | — | 5,340,000USD | 7,664,000USD | — | — |
| Unclassified Current Liabilities | — | — | — | — | — | -60,093,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,125,663,000USD | 343,734,000USD | 412,900,000USD | 717,422,000USD | 2,612,632,000USD | 2,901,765,000USD | 3,012,617,000USD | 2,430,402,000USD |
| Other Current Assets | 85,566,000USD | 21,762,000USD | 16,729,000USD | 19,237,000USD | -62,179,000USD | 292,984,000USD | -73,186,000USD | -25,805,000USD |
| Total Liab | 548,356,000USD | 2,842,572,000USD | 2,557,850,000USD | 2,419,535,000USD | 1,910,392,000USD | 2,208,525,000USD | 2,311,485,000USD | 1,866,557,000USD |
| Total Stockholder Equity | 577,307,000USD | -2,498,838,000USD | -2,144,950,000USD | -1,702,113,000USD | 702,240,000USD | 693,240,000USD | 701,132,000USD | 563,845,000USD |
| Other Current Liab | 87,770,000USD | 63,992,000USD | 56,028,000USD | 51,110,000USD | 130,107,000USD | 55,616,000USD | 99,208,000USD | 112,240,000USD |
| Common Stock | 283,000USD | 38,000USD | 38,000USD | 138,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Capital Stock | 283,000USD | 38,000USD | 38,000USD | 138,000USD | — | — | — | — |
| Retained Earnings | -2,548,736,000USD | -2,472,300,000USD | -2,119,175,000USD | -1,678,650,000USD | 503,321,000USD | 493,294,000USD | 471,112,000USD | 397,640,000USD |
| Good Will | 19,344,000USD | 19,344,000USD | 19,344,000USD | 19,344,000USD | — | 15,794,000USD | 15,794,000USD | 15,794,000USD |
| Cash | 797,799,000USD | 63,950,000USD | 56,402,000USD | 107,191,000USD | 53,547,000USD | 46,464,000USD | 45,315,000USD | 35,420,000USD |
| Cash And Short Term Investments | 800,094,000USD | 66,151,000USD | 121,586,000USD | 409,624,000USD | 132,539,000USD | 46,464,000USD | 121,290,000USD | 65,483,000USD |
| Total Current Assets | 997,800,000USD | 215,729,000USD | 242,612,000USD | 516,044,000USD | 214,662,000USD | 499,128,000USD | 220,021,000USD | 140,339,000USD |
| Total Current Liabilities | 127,145,000USD | 165,423,000USD | 95,138,000USD | 136,906,000USD | 320,250,000USD | 287,406,000USD | 425,533,000USD | 259,931,000USD |
| Net Debt | -418,807,000USD | 360,309,000USD | 160,872,000USD | 163,681,000USD | 1,692,184,000USD | 2,051,752,000USD | 2,113,699,000USD | 1,667,402,000USD |
| Short Term Debt | 169,000USD | 66,170,000USD | 6,754,000USD | 57,093,000USD | 183,448,000USD | 218,094,000USD | 311,381,000USD | 132,049,000USD |
| Short Long Term Debt Total | 378,992,000USD | 424,259,000USD | 217,274,000USD | 270,872,000USD | 1,745,731,000USD | 2,098,216,000USD | 2,159,014,000USD | 1,702,822,000USD |
| Long Term Debt | 378,450,000USD | 319,195,000USD | 166,106,000USD | 169,574,000USD | — | — | — | — |
| Short Term Investments | 2,295,000USD | 2,201,000USD | 65,184,000USD | 302,433,000USD | 78,992,000USD | — | 75,975,000USD | 30,063,000USD |
| Net Receivables | 112,140,000USD | 88,244,000USD | 55,299,000USD | 40,227,000USD | 144,302,000USD | 159,680,000USD | 171,917,000USD | 100,661,000USD |
| Inventory | 63,625,000USD | 39,572,000USD | 48,998,000USD | 46,956,000USD | — | — | — | — |
| Accounts Payable | 39,206,000USD | 27,791,000USD | 26,680,000USD | 27,269,000USD | 3,666,000USD | 7,291,000USD | 7,371,000USD | 7,831,000USD |
| Property Plant Equipment Net | 63,170,000USD | 102,767,000USD | 147,514,000USD | 138,049,000USD | 1,781,321,000USD | 1,820,735,000USD | 2,266,224,000USD | 2,005,299,000USD |
| Property Plant Equipment Gross | 304,150,000USD | 331,376,000USD | 331,650,000USD | 273,151,000USD | — | — | — | — |
| Accumulated Other Comprehensive Income | 936,000USD | 210,000USD | 218,000USD | 1,698,000USD | -5,743,000USD | -6,630,000USD | -6,513,000USD | -6,122,000USD |
| Common Stock Shares Outstanding | 1,672,056,160shares | 254,662,668shares | 254,662,668shares | 254,788,878shares | 17,949,000shares | 18,011,000shares | 19,818,000shares | 19,607,000shares |
| Non Current Assets Total | 127,863,000USD | 128,005,000USD | 170,288,000USD | 201,378,000USD | 2,397,970,000USD | 2,402,637,000USD | 2,792,596,000USD | 2,290,063,000USD |
| Non Current Liabilities Total | 421,211,000USD | 2,677,149,000USD | 2,462,712,000USD | 2,282,629,000USD | 1,590,142,000USD | 1,921,119,000USD | 1,885,952,000USD | 1,606,626,000USD |
| Non Currrent Assets Other | 45,349,000USD | 5,894,000USD | 3,430,000USD | 43,985,000USD | 616,649,000USD | 66,497,000USD | 31,053,000USD | 14,797,000USD |
| Net Working Capital | 870,655,000USD | 50,306,000USD | 147,474,000USD | 379,138,000USD | — | — | — | — |
| Unclassified Current Assets | -63,625,000USD | — | — | — | -62,179,000USD | — | -73,186,000USD | -25,805,000USD |
| Unclassified Non Current Liabilities | 42,761,000USD | 2,357,954,000USD | 2,296,606,000USD | 2,113,055,000USD | 1,590,142,000USD | 1,921,119,000USD | 1,885,952,000USD | 1,606,626,000USD |
| Unclassified Equity | 3,124,541,000USD | -26,824,000USD | -26,069,000USD | -25,437,000USD | 204,660,000USD | 206,574,000USD | 236,531,000USD | 172,325,000USD |
| Current Deferred Revenue | — | 7,470,000USD | 5,676,000USD | 1,434,000USD | 3,029,000USD | 6,405,000USD | 7,573,000USD | 7,811,000USD |
| Short Long Term Debt | — | 60,000,000USD | 167,000USD | 52,789,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | -60,000,000USD | — | -52,789,000USD | — | — | — | — |
| Intangible Assets | — | — | — | — | — | 4,123,000USD | 5,733,000USD | 7,723,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | 495,488,000USD | 473,792,000USD | 246,450,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 11,603,000USD |
| Stock Based Compensation | 38,091,000USD |
| Other Non Cash Items | -25,205,000USD |
| Change To Account Receivables | -4,749,000USD |
| Change To Liabilities | 49,732,000USD |
| Change In Working Capital | 33,453,000USD |
| Operating Cash Flow | 61,353,000USD |
| Capital Expenditures | -32,417,000USD |
| Net Investments | -100,117,000USD |
| Investing Cash Flow | -132,534,000USD |
| Net Debt Issuance | -82,000USD |
| Common Stock Issuance | 2,937,000USD |
| Net Common Stock Issuance | -26,681,000USD |
| Unclassified Financing Cash Flow | -12,253,000USD |
| Financing Cash Flow | -36,079,000USD |
| Effect Of Forex Changes On Cash | -37,000USD |
| Change In Cash | -107,297,000USD |
| End Cash Flow | 692,745,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q3 20212021-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -510,000USD | 81,957,000USD | 24,325,000USD | -71,789,000USD | -102,581,000USD | -66,186,000USD | -111,028,000USD | 51,155,000USD |
| Depreciation | 5,065,000USD | 4,291,000USD | 7,333,000USD | 6,409,000USD | 7,045,000USD | 11,610,000USD | 17,705,000USD | 32,882,000USD |
| Stock Based Compensation | 15,872,000USD | 13,367,000USD | 13,655,000USD | 28,293,000USD | 14,691,000USD | 4,485,000USD | 4,458,000USD | 566,000USD |
| Other Non Cash Items | 20,032,999USD | 4,261,000USD | 3,754,000USD | 45,814,000USD | 36,186,000USD | -8,718,000USD | 16,124,000USD | -12,995,000USD |
| Change To Account Receivables | 21,623,000USD | -91,021,000USD | 24,192,000USD | 29,127,000USD | 7,913,000USD | -14,526,000USD | -2,378,000USD | -15,736,000USD |
| Change To Inventory | -13,328,000USD | -9,606,000USD | -8,523,000USD | -4,682,000USD | 2,061,000USD | 3,480,000USD | 4,024,000USD | 42,620,000USD |
| Change In Working Capital | 8,288,000USD | -59,096,000USD | 13,358,000USD | -1,439,000USD | 13,321,000USD | -4,117,000USD | -1,184,000USD | 21,599,000USD |
| Total Cash From Operating Activities | 32,875,999USD | 44,780,000USD | 62,425,000USD | 7,288,000USD | -31,338,000USD | -62,926,000USD | -73,925,000USD | 97,613,000USD |
| Capital Expenditures | -10,341,999USD | -5,090,000USD | -7,095,000USD | -1,386,000USD | -2,689,000USD | -2,588,000USD | -1,738,000USD | -545,174,000USD |
| Free Cash Flow | 22,534,000USD | 39,690,000USD | 55,330,000USD | 5,902,000USD | -34,027,000USD | -65,514,000USD | -75,663,000USD | -447,561,000USD |
| Total Cashflows From Investing Activities | -10,342,000USD | -5,090,000USD | -7,095,000USD | -1,386,000USD | -2,689,000USD | -2,588,000USD | 59,638,000USD | -515,355,000USD |
| Net Borrowings | -40,000USD | 3,961,000USD | -23,000USD | 23,843,000USD | -22,000USD | -30,000USD | 199,898,000USD | — |
| Total Cash From Financing Activities | 824,000USD | 3,399,000USD | -21,097,000USD | 681,402,000USD | 1,285,000USD | -129,000USD | 200,108,000USD | 428,812,000USD |
| Sale Purchase Of Stock | 0USD | -91,000USD | -16,559,999USD | 22,000USD | -22,000USD | 0USD | 0USD | — |
| Change In Cash | 23,348,000USD | 43,060,000USD | 34,295,000USD | 687,397,000USD | -32,738,000USD | -65,631,000USD | 185,822,000USD | 11,083,000USD |
| Begin Period Cash Flow | 797,799,000USD | 756,982,000USD | 722,687,000USD | 35,290,000USD | 68,028,000USD | 245,829,000USD | 60,007,000USD | 51,229,000USD |
| End Period Cash Flow | 821,147,000USD | 800,042,000USD | 756,982,000USD | 722,687,000USD | 35,290,000USD | 180,198,000USD | 245,829,000USD | 62,312,000USD |
| Other Cashflows From Financing Activities | -56,000USD | -4,333,000USD | -4,514,000USD | 646,099,000USD | 1,329,000USD | -99,000USD | 210,000USD | 436,224,000USD |
| Unclassified Operating Cash Flow | -15,872,000USD | — | — | — | — | — | — | 4,406,000USD |
| Investments | — | 0USD | -7,095,000USD | -1,386,000USD | -2,689,000USD | -2,588,000USD | 59,638,000USD | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | 2,689,000USD | — | — | — | — | — | 29,819,000USD |
| Unclassified Investing Cash Flow | — | -2,689,000USD | 7,095,000USD | 1,386,000USD | 2,689,000USD | 2,588,000USD | 1,738,000USD | — |
| Unclassified Financing Cash Flow | — | 3,862,000USD | — | 11,438,000USD | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | -7,412,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -68,088,000USD | -281,890,000USD | -341,415,000USD | -320,827,000USD | 27,733,000USD | 31,011,000USD | 78,596,000USD | 72,060,000USD |
| Depreciation | 22,615,000USD | 48,913,000USD | 49,001,000USD | 48,253,000USD | 110,650,000USD | 113,927,000USD | 123,483,000USD | 113,263,000USD |
| Stock Based Compensation | 70,006,000USD | 18,643,000USD | 15,241,000USD | 22,901,000USD | 1,775,000USD | 2,758,000USD | 2,867,000USD | 2,087,000USD |
| Other Non Cash Items | 91,749,000USD | -1,798,000USD | 8,202,000USD | -13,777,000USD | 452,799,000USD | -314,667,000USD | 58,278,000USD | 73,468,000USD |
| Change To Account Receivables | -29,789,000USD | -33,816,000USD | -15,081,000USD | -11,905,000USD | 10,999,000USD | 3,864,000USD | -19,269,000USD | -7,802,000USD |
| Change To Inventory | -20,750,000USD | 5,459,000USD | -4,435,000USD | -11,103,000USD | — | — | 138,846,000USD | 38,861,000USD |
| Change In Working Capital | -33,127,000USD | -29,067,000USD | -7,129,000USD | -22,256,000USD | -317,310,000USD | 417,234,000USD | -85,920,000USD | -90,739,000USD |
| Total Cash From Operating Activities | 83,155,000USD | -245,199,000USD | -276,100,000USD | -285,706,000USD | 277,016,000USD | 253,997,000USD | 179,770,000USD | 155,192,000USD |
| Capital Expenditures | -16,260,000USD | -8,444,000USD | -22,319,000USD | -42,255,000USD | -219,450,000USD | -319,142,000USD | -812,844,000USD | -502,176,000USD |
| Free Cash Flow | 66,895,000USD | -253,643,000USD | -298,419,000USD | -327,961,000USD | 57,566,000USD | -65,145,000USD | -633,074,000USD | -346,984,000USD |
| Investments | 0USD | 52,932,000USD | 214,774,000USD | -282,986,000USD | — | — | — | — |
| Total Cashflows From Investing Activities | -16,260,000USD | 52,932,000USD | 214,774,000USD | -282,986,000USD | -33,968,000USD | -271,869,000USD | -663,343,000USD | -411,751,000USD |
| Net Borrowings | 27,759,000USD | 199,821,000USD | 10,567,000USD | -962,000USD | — | — | — | — |
| Total Cash From Financing Activities | 664,989,000USD | 200,292,000USD | 10,132,000USD | 10,445,000USD | -249,882,000USD | -108,479,000USD | 512,350,000USD | 245,625,000USD |
| Sale Purchase Of Stock | -113,000USD | 0USD | 0USD | — | -7,946,000USD | -34,118,000USD | -40,869,000USD | — |
| Issuance Of Capital Stock | 649,697,000USD | 0USD | 0USD | — | — | — | — | — |
| Change In Cash | 732,014,000USD | 8,021,000USD | -51,132,000USD | -558,245,000USD | -6,737,000USD | -2,744,000USD | 28,774,000USD | -10,714,000USD |
| Begin Period Cash Flow | 68,028,000USD | 60,007,000USD | 111,139,000USD | 669,384,000USD | 73,239,000USD | 75,983,000USD | 47,209,000USD | 46,134,000USD |
| End Period Cash Flow | 800,042,000USD | 68,028,000USD | 60,007,000USD | 111,139,000USD | 66,502,000USD | 73,239,000USD | 75,983,000USD | 35,420,000USD |
| Other Cashflows From Financing Activities | -18,551,000USD | 471,000USD | -435,000USD | 11,407,000USD | -232,176,000USD | -99,651,000USD | 515,610,000USD | 245,625,000USD |
| Unclassified Financing Cash Flow | 655,894,000USD | — | — | — | 7,946,000USD | 34,118,000USD | 40,869,000USD | — |
| Unclassified Investing Cash Flow | — | 8,444,000USD | 22,319,000USD | 42,255,000USD | — | — | 43,352,000USD | 24,061,000USD |
| Dividends Paid | — | — | — | — | -17,706,000USD | -8,828,000USD | -3,260,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | 185,482,000USD | 47,273,000USD | 106,149,000USD | 66,364,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | 3,734,000USD | 2,466,000USD | -14,947,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | International | 2,140,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 261,572,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Molecular Profiling Services | 252,254,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Pharma Research And Development Services | 11,458,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 2,338,000 | USD | 0002019410-26-000044 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 213,836,000 | USD | 0002019410-26-000044 |
| Q1 2026Quarterly · 2026-03-31 | Product | Molecular Profiling Services | 210,800,000 | USD | 0002019410-26-000044 |
| Q1 2026Quarterly · 2026-03-31 | Product | Pharma Research And Development Services | 5,374,000 | USD | 0002019410-26-000044 |
| Q4 2025Quarterly · 2025-12-31 | Geography | International | 1,653,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 291,234,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Molecular Profiling Services | 282,127,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Pharma Research And Development Services | 10,760,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 10,640,000 | USD | 0002019410-26-000016 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 801,393,000 | USD | 0002019410-26-000016 |
| FY 2025Yearly · 2025-12-31 | Product | Molecular Profiling Services | 766,719,000 | USD | 0002019410-26-000016 |
| FY 2025Yearly · 2025-12-31 | Product | Pharma Research And Development Services | 45,314,000 | USD | 0002019410-26-000016 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 3,283,000 | USD | 0002019410-25-000028 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 213,550,000 | USD | 0002019410-25-000028 |
| Q3 2025Quarterly · 2025-09-30 | Product | Molecular Profiling Services | 207,587,000 | USD | 0002019410-25-000028 |
| Q3 2025Quarterly · 2025-09-30 | Product | Pharma Research And Development Services | 9,246,000 | USD | 0002019410-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 3,221,000 | USD | 0002019410-25-000012 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 178,177,000 | USD | 0002019410-25-000012 |
| Q2 2025Quarterly · 2025-06-30 | Product | Molecular Profiling Services | 162,924,000 | USD | 0002019410-25-000012 |
| Q2 2025Quarterly · 2025-06-30 | Product | Pharma Research And Development Services | 18,474,000 | USD | 0002019410-25-000012 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 2,483,000 | USD | 0002019410-26-000044 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 118,432,000 | USD | 0002019410-26-000044 |
| Q1 2025Quarterly · 2025-03-31 | Product | Molecular Profiling Services | 114,081,000 | USD | 0002019410-26-000044 |
| Q1 2025Quarterly · 2025-03-31 | Product | Pharma Research And Development Services | 6,834,000 | USD | 0002019410-26-000044 |
| FY 2024Yearly · 2024-12-31 | Geography | International | 10,424,000 | USD | 0002019410-26-000016 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 401,836,000 | USD | 0002019410-26-000016 |
| FY 2024Yearly · 2024-12-31 | Product | Molecular Profiling Services | 349,115,000 | USD | 0002019410-26-000016 |
| FY 2024Yearly · 2024-12-31 | Product | Pharma Research And Development Services | 63,145,000 | USD | 0002019410-26-000016 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 2,217,000 | USD | 0002019410-25-000028 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 99,403,000 | USD | 0002019410-25-000028 |
| Q3 2024Quarterly · 2024-09-30 | Product | Molecular Profiling Services | 93,803,000 | USD | 0002019410-25-000028 |
| Q3 2024Quarterly · 2024-09-30 | Product | Pharma Research And Development Services | 7,817,000 | USD | 0002019410-25-000028 |
| Q2 2024Quarterly · 2024-06-30 | Geography | International | 2,668,000 | USD | 0002019410-25-000012 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 97,381,000 | USD | 0002019410-25-000012 |
| Q2 2024Quarterly · 2024-06-30 | Product | Molecular Profiling Services | 87,656,000 | USD | 0002019410-25-000012 |
| Q2 2024Quarterly · 2024-06-30 | Product | Pharma Research And Development Services | 12,393,000 | USD | 0002019410-25-000012 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 12,720,000 | USD | 0002019410-26-000016 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 293,408,000 | USD | 0002019410-26-000016 |
| FY 2023Yearly · 2023-12-31 | Product | Molecular Profiling Services | 278,748,000 | USD | 0002019410-26-000016 |
| FY 2023Yearly · 2023-12-31 | Product | Pharma Research And Development Services | 27,380,000 | USD | 0002019410-26-000016 |
| FY 2020Yearly · 2020-12-31 | Geography | Asia | 58,283,000 | USD | 0001388430-21-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | CH | 54,023,000 | USD | 0001388430-21-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe | 57,893,000 | USD | 0001388430-21-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | France | 31,972,000 | USD | 0001388430-21-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | International | 3,327,000 | USD | 0001388430-21-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | Singapore | 41,748,000 | USD | 0001388430-21-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | South Korea | 42,011,000 | USD | 0001388430-21-000004 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 4,756,000 | USD | 0001388430-21-000004 |
| Q3 2020Quarterly · 2020-09-30 | Segment | Container Leasing | 73,890,000 | USD | 0001388430-20-000015 |
| Q3 2020Quarterly · 2020-09-30 | Segment | Rail Leasing | 5,162,000 | USD | 0001388430-20-000015 |
| Q2 2020Quarterly · 2020-06-30 | Segment | Container Leasing | 69,443,000 | USD | 0001388430-20-000009 |
| Q2 2020Quarterly · 2020-06-30 | Segment | Rail Leasing | 6,282,000 | USD | 0001388430-20-000009 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Container Leasing | 69,113,000 | USD | 0001388430-20-000007 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Logistics | 30,106,000 | USD | 0001388430-20-000007 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Rail Leasing | 5,803,000 | USD | 0001388430-20-000007 |
| FY 2019Yearly · 2019-12-31 | Geography | Asia | 58,349,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Geography | CH | 50,118,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Geography | Europe | 63,141,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Geography | France | 34,947,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Geography | International | 1,767,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Geography | Singapore | 41,626,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Geography | South Korea | 42,257,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 6,648,000 | USD | 0001388430-21-000004 |
| FY 2019Yearly · 2019-12-31 | Product | Container Lease Revenue | 298,853,000 | USD | 0001388430-20-000003 |
| FY 2019Yearly · 2019-12-31 | Product | Logistics Revenue | 117,687,000 | USD | 0001388430-20-000003 |
| FY 2019Yearly · 2019-12-31 | Segment | Container Leasing | 298,853,000 | USD | 0001388430-20-000003 |
| FY 2019Yearly · 2019-12-31 | Segment | Logistics | 117,687,000 | USD | 0001388430-20-000003 |
| Q3 2019Quarterly · 2019-09-30 | Segment | Container Leasing | 75,535,000 | USD | 0001388430-20-000015 |
| Q3 2019Quarterly · 2019-09-30 | Segment | Rail Leasing | 5,871,000 | USD | 0001388430-20-000015 |
| Q2 2019Quarterly · 2019-06-30 | Segment | Container Leasing | 74,286,000 | USD | 0001388430-20-000009 |
| Q2 2019Quarterly · 2019-06-30 | Segment | Rail Leasing | 6,462,000 | USD | 0001388430-20-000009 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Container Leasing | 75,511,000 | USD | 0001388430-20-000007 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Logistics | 27,716,000 | USD | 0001388430-20-000007 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Rail Leasing | 7,881,000 | USD | 0001388430-20-000007 |
| FY 2018Yearly · 2018-12-31 | Geography | Asia | 67,695,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Geography | CH | 50,805,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Geography | Europe | 54,677,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Geography | France | 37,565,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Geography | International | 8,198,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Geography | Singapore | 26,854,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Geography | South Korea | 31,877,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 7,253,000 | USD | 0001388430-21-000004 |
| FY 2018Yearly · 2018-12-31 | Product | Container Lease Revenue | 284,924,000 | USD | 0001388430-20-000003 |
| FY 2018Yearly · 2018-12-31 | Product | Logistics Revenue | 111,471,000 | USD | 0001388430-20-000003 |
| Q4 2018Quarterly · 2018-12-31 | Segment | Container Leasing | 76,626,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Segment | Logistics | 30,220,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Segment | Rail Leasing | 8,721,000 | USD | Legacy provider |
| FY 2018Yearly · 2018-12-31 | Segment | Container Leasing | 284,924,000 | USD | 0001388430-20-000003 |
| FY 2018Yearly · 2018-12-31 | Segment | Logistics | 111,471,000 | USD | 0001388430-20-000003 |
| Q3 2018Quarterly · 2018-09-30 | Segment | Container Leasing | 75,331,000 | USD | 0001388430-19-000013 |
| Q3 2018Quarterly · 2018-09-30 | Segment | Logistics | 31,362,000 | USD | 0001388430-19-000013 |
| FY 2017Yearly · 2017-12-31 | Geography | Asia | 64,097,000 | USD | 0001388430-20-000003 |
| FY 2017Yearly · 2017-12-31 | Geography | CH | 32,430,000 | USD | 0001388430-20-000003 |
| FY 2017Yearly · 2017-12-31 | Geography | Europe | 45,176,000 | USD | 0001388430-20-000003 |
| FY 2017Yearly · 2017-12-31 | Geography | France | 34,862,000 | USD | 0001388430-20-000003 |
| FY 2017Yearly · 2017-12-31 | Geography | International | 10,659,000 | USD | 0001388430-20-000003 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.